Citius Oncology Inc.CTORNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P33
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 9.31% |
| 2024 | 98.56% |
| 2023 | 175.80% |
| 2022 | 0.00% |
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| 2025 | 9.31% |
| 2024 | 98.56% |
| 2023 | 175.80% |
| 2022 | 0.00% |